Citation Impact
61 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Ganesh Moorthy being referenced
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors
2022
Abstract CT026: Evidence of immune activation in the first-in-human Phase Ia dose escalation study of the adenosine 2a receptor antagonist, AZD4635, in patients with advanced solid tumors
2019
Author Peers
| Author | Molecular Biology | Oncology | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Ganesh Moorthy | 180 | 149 | 94 | 22 | 434 | |
| Tarla Shah | 10 | 277 | ||||
| Elizabeth McWhinnie | 573 | 77 | 9 | 10 | 775 | |
| Yousuke Tate | 5 | 5 | 6 | 335 | ||
| Fernando Méndez-Hermida | 3 | 6 | 13 | 402 | ||
| Leonidas K. Cheliotis | 50 | 388 |
All Works
Login with ORCID to disown or claim papers
Loading papers...